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Abstract 
Objectives: To use the Theoretical Domains Framework (TDF) to identify barriers and enablers to participant retention in trials 
requiring questionnaire return and/or attendance at follow-up clinics. 
Study design and setting: We invited participants (n = 607) from five pragmatic effectiveness trials, who missed at least one 
follow-up time point (by not returning a questionnaire and/or not attending a clinic visit), to take part in semistructured telephone 
interviews. The TDF informed both data collection and analysis. To establish what barriers and enablers most likely influence the target 
behavior the domain relevance threshold was set at > 75% of participants mentioning the domain. 
Results: Sixteen participants (out of 25 showing interest) were interviewed. Overall, seven theoretical domains were identified as 
both barriers and enablers to the target behaviors of attending clinic appointments and returning postal questionnaires. Barriers frequently 
reported in relation to both target behaviours stemmed from participants’ knowledge, beliefs about their capabilities and the consequences 
of performing (or not performing) the behavior. Two domains were identified as salient for questionnaire return only: goals; and memory, 
attention and decision-making. Emotion was identified as relevant for clinic attendance only. 
Conclusion: This is the first study informed by behavioural science to explore trial participants’ accounts of trial retention. Findings 
will serve as a guiding framework when designing trials to limit barriers and enhance enablers of retention within clinical trials. ©
2021 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license ( http:// creativecommons.org/ licenses/ 
by- nc- nd/ 4.0/ ) 







One of the main threats to the successful delivery of
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( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) undermines both internal and external validity and is par-
ticularly problematic if the data are missing not at random
(e.g., there is differential loss to follow-up in the control
and intervention arms). However, missingness at random
can still cause problems. Approximately 50% of trials lose
over 11% of follow-up data [1] . Furthermore, the results
of around half of clinical trials could have been overturned
if the outcomes from nonretainers were known [2] . Thisder the CC BY-NC-ND license 



































































































highlights the critical need to understand how to retain
participants in a trial until the end. 
Whilst there has been extensive methodological research
on recruitment to trials, the same cannot be said for re-
tention. A recent evidence synthesis of qualitative stud-
ies identified only 11 studies that had explored any aspect
of trial retention with participants who had not completed
the trial until the end [3] . While it may be hard to re-
engage with former participants to understand why trials
fail to retain them, the lack of knowledge about this issue
is striking. One explanation for this gap may be that, unlike
recruitment, the problem of poor retention might look as
though it can be adjusted for with statistical methods, such
as complete case analysis or imputation. But, as Vickers
and Altman argued in 2013, an informed guess, even one
based on sophisticated statistical methods, is still a guess
[4] . It is more reliable, efficient, and ethical to avoid miss-
ing data in the first place by considering aspects of trial de-
sign that are amenable to improving trial retention. To date,
very few interventions have been shown to improve reten-
tion in RCTs, with only moderate certainty evidence avail-
able for the use of monetary rewards with a prompts or
reminder to improve responses to postal questionnaires [5] .
Yet, none of the retention interventions to date has been
informed by evidence on the perspectives of participants
and/or former participants from a range of trials and what
they experience as barriers and enablers to trial retention.
Therefore, the acceptability of trial retention interventions
to those for whom the interventions are intended remains
uncertain. 
Retention within clinical trials involves a behavior, with
participants asked to complete and return questionnaires
and/or attend research visits. Behavior change theories and
frameworks can provide a basis for identifying modifi-
able determinants of nonretention, and for developing a
cumulative evidence base of methods that could be used
to improve retention within clinical trials. Theory-based
interventions for retention show initial promise, such as
cover letters with behavior change techniques embedded
within them to encourage questionnaire response [6] . One
common approach used to apply behavior change theory
within health research is the Theoretical Domains Frame-
work (TDF– see Box 1 for domains and definitions) [7 , 8] .
Recent interview studies have utilized the TDF to ex-
plore barriers and enablers to enacting behaviors within
clinical trials, such as intervention delivery and partici-
pant recruitment [9–11] . However, the TDF has not pre-
viously been used to identify barriers and enablers to re-
tention in trials from the perspectives of trial participants
[12] . 
The aim of this study was to use this theory-
based behavioral framework to identify barriers and
enablers to participant retention in trials requiring
questionnaire return and/or attendance at follow-up
clinics.  
2. Methods 
The study reported in this manuscript involved a quali-
tative investigation to identify and assess problems with
participant retention in clinical trials by identifying the
salient behavioural domains. This work is the first phase
in a larger project that aims to develop theoretically in-
formed and participant-centered interventions to target re-
tention [13] . 
3. Participant recruitment 
Five phase III pragmatic effectiveness trials recruiting
adults were selected purposively. This trial selection was
based on the potential influence of a number of factors
on the follow-up of participants (e.g., number of question-
naires or clinic visits). These factors included: variability in
trial intervention (e.g., Clinical Trial of an Investigational
Medicinal Product (CTIMPs) and non-CTIMPs); and pop-
ulation (e.g., age, gender); trials known to be at risk of
poor retention (i.e., online trials); and poor retention (i.e.,
trials with > 15% missing primary outcome data, identified
when contacted by STEER study team). Trials currently in
active follow-up or recently completed that fulfilled these
criteria were identified through the clinical trials units and
associated networks linked to the project team. We iden-
tified and subsequently invited participants from included
trials to take part in a telephone interview study. These
participants had discontinued their trial participation for at
least one follow-up time point (i.e., they could have missed
any/all number of follow ups but had to have missed at
least one) either by not returning a questionnaire and/or
not attending a clinic visit within the preceding 12 months.
We also used social media to invite trial participants from
additional trials who met these criteria for discontinued
participation. 
An invitation letter and participant information leaflet
(PIL), co-developed with the project patient partners (J.E.
and M.O.), were sent to all potential participants by post
or by email, depending on the contact details held for par-
ticipants. Invitation letters were sent out from each host
trial’s office to keep personal information of potential par-
ticipants confidential. A detachable reply-slip to complete
and return to the researcher (in a reply-paid envelope) to
indicate interest was included. A researcher (R.N.) then
contacted the interested participants to discuss the study
further. Two attempts were made to engage with poten-
tial participants who had expressed interest. An informa-
tion letter informed by behavioral theory was introduced
to encourage participation 4 months into the study. A total
of 607 invitations were sent with the aim of interviewing
30 participants (six from each of the five trials) informed
by by five key aspects of information power: whether the
study aim is broad or narrow (with a focused aim requir-
ing a smaller sample); dense or sparse sample specificity
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Box 1. Theoretical domains framework definitions and associated questions. The TDF summarizes 33 behavior change theories – and thus a wide 
breadth of modifiable factors that have been linked with behavior and behavior change – into 14 theoretical domains [Cane et al 2012]. 
TDF domain Definition 
Knowledge An awareness of the existence of something 
Skills An ability or proficiency acquired through practice 
Social/professional role 
and identity 
A coherent set of behaviours and displayed personal qualities of an individual in a social or work 
setting 
Beliefs about capabilities Acceptance of the truth, reality, or validity about an ability, talent, or facility that a person can put to 
constructive use 
Optimism The confidence that things will happen for the best or that desired goals will be attained 
Beliefs about 
consequences 
Acceptance of the truth, reality, or validity about outcomes of a behaviour in a given situation 
Reinforcement Increasing the probability of a response by arranging a dependent relationship, or contingency, 
between the response and a given stimulus 
Intentions Conscious decision to perform a behaviour or a resolve to act in a certain way 
Goals Mental representations of outcomes or end states that an individual wants to achieve 
Memory, attention, and 
decision processes 
Ability to retain information, focus selectively on aspects of the environment, and choose between 2 
or more alternatives 
Environmental context 
and resources 
Any circumstance of a person’s situation or environment that discourages or encourages the 
development of skills and abilities, independence, social competence, an adaptive behavior 
Social influences Interpersonal processes that can cause individuals to change their thoughts, feelings, or behaviors 
Emotions Complex reaction pattern, involving experiential, behavioural, and physiological elements, by which 
the individual attempts to deal with a personally significant matter or event 


















































(where dense specificity requires a smaller sample); appli-
cation or not of established theory (theoretical perspec-
tives requiring smaller sample); quality of the dialogue
(with strong clear communication requiring less); and fi-
nally, whether case or cross-case analysis (with cross-case
requiring more participants) [14] . 
4. Data generation 
We conducted one-to-one semistructured telephone in-
terviews with participants. Interviews explored partici-
pants’ experiences of the trial, reasons for trial discontinua-
tion, what could have been done to enable them to remain
in the trial until its completion (Appendix 1). The topic
guide was informed by the TDF, refined by the research
team, and used adaptively to ensure interviews were con-
versational and participants could raise issues that were
important from their perspective. Following pilot testing
in the first three interviews, the topic guide was further
refined to ensure its comprehensibility, acceptability, and
theoretical robustness. Follow-up prompts were included
when necessary to address specific constructs within the
domains. 
Interviews were conducted by a researcher (R.N.) who
was independent from the trials and who sought verbal in-
formed consent from each participant. All interviews were
audio-recorded and transcribed verbatim. The quality of
each transcript was checked against the original recordings.
The fidelity of the use of the topic guide was checked byanother two researchers (K.G. and J.P.) who listened to the
first two interview recordings and/or read the transcripts. 
5. Data analysis 
Anonymized interview transcripts were imported into
Vivo qualitative analysis software version 12 to assist data
management and coding. A coding guide was developed
based on the published definitions and constructs of the
TDF domains and agreed (R.N. and J.P.) for the purpose
of consistent coding. Three transcripts were randomly se-
lected and coded independently by two researchers (R.N.
and J.P.) and discussed during a face-to-face meeting to
ensure fidelity of the coding guide. Using the agreed cod-
ing guide, verbatim data were first coded (R.N.) to specific
theoretical domains of the TDF. Each domain had two be-
haviors (retention behavior related to: (1) questionnaire re-
turn and (2) clinic visit). Next, statements (including both
barriers and facilitators, determined by participants framing
as positive or negative) related to retention were collated
and grouped into sub-themes under each theme (i.e., clinic
visit or questionnaire return) of the related domains. 
To establish what barriers and enablers influence the
target behavior (i.e., participant retention in trials), criteria
were developed to determine which domains of the TDF
were “relevant’” for this behavior. The predetermined rele-
vance threshold was based on > 50% of participants report-
ing a barrier or facilitator for a given domain, as per criteria
from other studies [15 , 16] . However, on analysis it became
apparent this threshold was not specific enough and there-



























































































fore the decision to increase this threshold to > 75% was
made to allow more defined targeting in later intervention
development. Barriers and enablers were considered sepa-
rately for each domain when considering relevance. Only
interviewees’ responses on domains determined as relevant
to the target behaviors are reported in detail. 
6. Patient and public involvement 
Two public partners (J.E. and M.O.) were part of the
study team and involved at several stages including the
development of study protocol, the design of the study
materials, ethics application, and discussion at the steering
committee’s quarterly meetings. They also had consider-
able input into the phrasing of the topic guide questions.
Our public partners have extensive experience of working
across a range of health research projects, funding pan-
els, and policy roles (e.g., patient and public involvement
lead for the Health Research Authority) and so have an in
depth understanding of randomized trials. Whilst the pub-
lic partners on the study did not have any direct experience
of trial participation themselves, the wider STEER project
that this study falls within has patient involvement across
intervention design and acceptability phases through input
into co-design activities. 
7. Results 
7.1. Sample characteristics 
Of the 607 trial participants invited, 25 indications of
interests were received (response rate of 4%). From these
25, 16 participants were interviewed between November
2017 and March 2019 with the remaining 9 proving to
be uncontactable. Participants’ ages ranged from 31 to 90
years (median = 58), and nine were male (56%) and all
were White. Participants were from five UK trials with one
further participant recruited through social media. Across
the sample, 7 of 16 (from two trials) of the interview par-
ticipants took part in trials that required both questionnaire
return and clinic visits to collect outcome data, and 9 of
16 (from four trials) took part in trials where trial ques-
tionnaire return only was required. The interviews lasted
between 17 and 80 minutes (median 39 minutes). See
Table 1 for trial and participant characteristics. 
7.2. Interview findings 
Overall participants were mostly unaware of being con-
sidered by their trial teams as lost to follow-up. The ma-
jority presumed that the study was complete, or that they
might be still taking part but was not certain about this.
Most could not recall the total duration of the trial or the
duration of their involvement. When considering their par-
ticipation in the trial, most participants perceived them-
selves to be a “private person” as they don’t normally dis-close health and personal-life related information (i.e., rea-
sons for taking part in the trial and/or not completing all
trial related activities) to others. However, they took part in
this interview study because they felt it was an opportunity
to share experiences and help improve future trials. Partic-
ipants described taking part in trials as an opportunity to
help others, doing a duty, a feeling of peace of mind, and
contributing to discovering whether a new treatment/drug
was effective. 
Behavioural barriers and enablers were identified across
the TDF domains for each of the specified behaviors (clinic
attendance then returning postal questionnaire). Table 2
presents the factors that influence clinic attendance and
questionnaire return across all TDF domains. Overall, there
were seven domains that were relevant for both attend-
ing clinic appointments and returning postal questionnaires
and identified as both barriers and enablers: knowledge;
beliefs about capabilities; environmental context and re-
sources; beliefs about consequences; reinforcements; be-
havioral regulation; and social influences. However, there
were two domains that were identified as salient for ques-
tionnaire return only: goals; and memory, attention and
decision-making (enabler only). Emotion was identified as
relevant for clinic attendance only. While the data were an-
alyzed separately for the two behaviors, because the find-
ings were remarkably similar for each, the summarized
findings are presented in parallel below for each relevant
domain with key contrasts highlighted. Data from partici-
pants in the form of quotes can be found in Supplemen-
tary Table S1 (attending clinical appointments) and Table
S2 (returning questionnaires). 
7.2.1. Knowledge 
All participants were aware that clinic visits and ques-
tionnaire return were involved in the trial they took part
in. However, only a minority was aware of the number and
frequency of visits or questionnaires involved and whether
they managed to attend them all or not. Some did not re-
alize that they had to return an identical questionnaire at
every follow-up time point and therefore found it repetitive
and boring, and hard to keep track of. 
7.2.2. Beliefs about capabilities 
Participants perceived themselves as being confident and
capable of attending clinic appointments if they were avail-
able on a suitable day and time. Enabling factors such as
the close proximity of the clinic to the participant’s home,
combining other activities (e.g., shopping, day out) with
the clinic visit and flexible appointment system offered by
the clinic (e.g., evening time after work) were mentioned as
helpful. Likewise, most participants perceived themselves
as capable of completing a questionnaire stating various
reasons such as: it was easy to complete and return an on-
line or a postal questionnaire using the pre-paid envelope,
clear instructions, not too long, and support from staff to
complete it during clinic visits. 
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Table 1. Host trial and participant characteristics 
Trial acronym, ISRCTN, title Brief description (population, primary 
outcome, timing of primary outcome, 
reminders and incentives/rewards) 




A UK multicentre RCT comparing 
laparoscopic cholecystectomy with 
observation/conservative management 
for preventing recurrent symptoms and 
complications in adults with 
uncomplicated symptomatic gallstones. 
- Adults with symptomatic uncomplicated 
gallstone disease- Primary 
outcome = self-reported quality of life- 3, 
9, 12 and 18 months post randomisation –
reminders sent for each time point 2 
weeks after due date.- 
Incentives/Rewards = None 
n = 3(male = 1, 
female = 2 / 53 y, 38 
y, 75 y) 
Return of postal 
questionnaires 
DISCO: ISRCTN89237370 
A UK online RCT of the effects of digital 
cognitive behavioural therapy (CBT) for 
insomnia on cognitive function. 
-Community participants (age 25 or over) 
meeting criteria for self-reported 
Insomnia Disorder 
-Primary outcome = self-reported 
cognitive impairment. 
-Online questionnaires at 10 and 24 
weeks post-randomisation. 
- 10 weeks (£10 gift voucher reward) 
and 24 weeks (£15 gift voucher reward) 
questionnaire. 
n = 2(female/ 52 y, 
57 y) 
Online return of 
questionnaires 
MASTER: ISRCTN49212975 A UK 
multicentre RCT evaluating the male 
synthetic sling versus Artificial urinary 
Sphincter Trial for men with urodynamic 
stress incontinence (USI) after prostate 
surgery. 
- Adult men with USI after prostate 
surgery, for whom surgery is judged 
appropriate-Primary 
outcome = self-reported incontinence.-12 
and 24 months post-randomization (up to 
two reminders sent at each time point and 
2 weeks after due 
date).-Incentives/Rewards = None 
n = 3(male/ 56 y, 72 
y, 75 y)) 
Return of postal 
questionnaire 
TISU: ISRCTN92289221 
A UK multicentre randomised controlled 
trial of extracorporeal shockwave 
lithotripsy, as first treatment option, 
compared with direct progression to 
ureteroscopic treatment, for ureteric 
stones. 
- Adults ( ≥16 Y) presenting with a ureteric 
stone within any segment of the ureter 
- Primary clinical and economic 
outcome = stone clearance (self-report 
of no further intervention) and quality 
adjusted life years (from EQ-5D 
self-report). 
-One week (postintervention), 8 weeks 
and 6 months post randomisation (up to 
two reminders sent by post, email or 
phone, considering any preferences 
participants had for mode of 
communication). 
-Incentives: £10 sent with the 6 month 
questionnaire 
n = 1(male, 60 y) Return of postal 
questionnaire 
INTERVAL: ISRCTN95933794 
A UK multicentre RCT investigating the 
best dental recall interval for optimum, 
cost-effective maintenance of oral 
health in dentate adults attending 
dental primary care. 
- Adults with periodontal disease 
-Primary outcome = self-reported 
quality of life and clinical assessment of 
periodontal disease. 
-Questionnaire: 3, 6, 12, and 24 
months post-randomization (up to two 
reminders sent at each time point) 
-Clinic visit: 6 months, 24 months, risk 
based recall (reminders via letters and/or 
phone calls sent at each time point). 
-Reward: £15 vouchers after returning 
24 months questionnaire and attending 
24 months clinic visit 
n = 6(male = 4, 
female = 2 / 31 y, 34 
y, 65 y, 69 y, 71 y, 90 
y) 
Return of postal 
questionnaires 
and clinic visits 
( continued on next page ) 
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Table 1 ( continued ) 
Trial acronym, ISRCTN, title Brief description (population, primary 
outcome, timing of primary outcome, 
reminders and incentives/rewards) 
Number of interviewees 
(gender, age) 
Target behaviour 
Participant identified through social media 
(Twitter). Participant reported detail of 
trial = Multicenter, double- blind, 
randomized, parallel-group, monotherapy, 
active-control study to determine the 
efficacy and safety of Daclizumab High 
Yield Process (DAC HYP) versus Avonex®
(Interferon β-1a) in patients with 
relapsing-remitting multiple sclerosis. 
Not available n = 1(female, 46 y) Return of postal 
questionnaires 
and clinic visits 













Barriers that impacted on participants’ beliefs about ca-
pabilities with regard to clinic visits included: an inabil-
ity to attend due to needing childcare, distance to travel,
availability and location of parking, inflexibility of appoint-
ments, and other life events such as attending other health-
related appointments (e.g., ante-natal or mental health) ortaking part in other research studies. The barriers people
cited to questionnaire return were different and included
a belief that they were “not good with paperwork” with
some lacking confidence and believing they were not ca-
pable of returning all questionnaires due to a dislike of
filling in paper/online forms or worries related to complet-






























































































ing the questionnaire “correctly” for the purpose of the
trial. Some discussed preferred options of returning ques-
tionnaires including online, postal or both. One practical
issue highlighted was the font size being too small. 
7.2.3. Environmental context and resources 
Participants suggested several situational or environ-
mental barriers related to clinic visits and questionnaire
return. These ranged from lack of time due to caring or
work commitments, financial issues (e.g., paying for trial
related activities such as parking/travel), not seeing any
other participants from the trial, disorganized and/or can-
celled appointments, duration of visit, and travel time re-
quired. Barriers relevant only to questionnaire return re-
lated to the design of the questionnaire such as a “bor-
ing,” “depressing,” “repetitive,” or “lengthy” question-
naires which discouraged them to return. 
Enablers that encouraged participants to attend clinic
appointments included having plenty of time due to no
competing priorities (e.g., retired) and a pleasant clinic at-
mosphere. Having no competing demands on their time
was also raised as an enabler for questionnaire return.
Some participants also reported the design and mode of
delivery of the questionnaire as enabling return as it was
easy to follow, and the online method or reply-paid en-
velopes supported this. 
7.2.4. Beliefs about consequences 
Both negative and positive consequences of attending a
clinic appointment were reported in this domain. Positives
for both behaviors centered on the belief they were help-
ing by taking part in a research study or feeling satisfied
that they were making a difference to others and bene-
fitting themselves (e.g., finding a solution for their health
issues). In addition, consequences of attending clinic visits
were seeing the clinician more often than usual and getting
additional clinical tests or checks done again related to a
belief of improving their health or care. 
The negatives of not attending a clinic appointment
or returning a questionnaire were that the trial may take
longer to complete, there may be a negative impact on re-
search findings, or participants “may get struck off” from
the trial. However, some participants could not identify any
downsides of not attending a clinic appointment or not
returning a questionnaire. This was largely because they
believed the trial office would send another questionnaire
or the clinic would reschedule their appointment. Finally,
while most participants believed their contributions made
a difference to the trial, some were unsure, and one men-
tioned personal disappointment in not finishing. 
7.2.5. Reinforcement 
When asked about what reinforced their behavior to at-
tend clinic visits or return questionnaires, monetary incen-
tives in the form of vouchers (i.e., if provided by a trial)
were well accepted by some participants who thought itwas a “nice gesture.” In contrast, others felt monetary in-
centives were not expected or needed or indeed felt these
were coercive and would deter them from participating
or completing the trial tasks. When asked about what in-
centives would be deemed acceptable both monetary (e.g.,
cash or vouchers) and nonmonetary (e.g., a thank-you note
or additional health check) incentives were proposed. A
few interviewees suggested that the offer to receive a sum-
mary of the findings following trial completion would have
been motivating, potentially encouraging them to take part
in future trials as well as complete a trial until the end. 
Participants mentioned a number of negative experi-
ences that deterred them from attending clinics, which
largely related to the demeanor of the staff and participants
not feeling valued. Conversely, clinic staff with a pleasant
demeanor encouraged clinic attendance and contributed to
a rewarding experience for participants. Participants men-
tioned that not receiving a response from the trial office
to their queries had deterred them from returning ques-
tionnaires further highlighting the impact of participants’
perceptions of trial staff on retention. 
7.2.6. Behavioral regulation 
Participants described the strategies (i.e., enablers) they
used to attend clinic appointments including arranging
childcare, putting the appointment date in the diary, cal-
endar or notes on their phone, arranging a “day out” to
coincide with the clinic visit. Strategies used by partic-
ipants for returning a questionnaire included putting the
questionnaire out in a visible place as a visual reminder,
allocating time to understand the questions and complete
then return it. However, some used no specific strategies
simply to complete and return the questionnaire. 
When participants were asked about what would have
made it easier for them to return the questionnaire, re-
sponses were largely linked to mode of delivery. For ex-
ample, an online questionnaire (compared to postal/paper
copy) would have been easier to complete and return to
the trial office. However, one participant stated a dislike
for online methods due to his older age and lack of com-
petence with technology. A few individuals suggested they
would like to complete a questionnaire over the phone but
others disliked this option because they would prefer time
to consider responses, or commented that they had a call
screening service that would screen out the number, or
their phone reception was poor. Reminders, such as text
messages, email, letters, or a repeat questionnaire, were
mentioned as a helpful prompt for both clinic attendance
and questionnaire return. 
7.2.7. Social influences 
As mentioned previously under reinforcement, partic-
ipants stated that the demeanor of the trial staff (at the
study office or at the clinic) impacted attendance at clini-
cal appointments and returning questionnaires. Participants
raised barriers such as no communication from the trial






























































































team, uncooperative trial staff (e.g., seemingly not pre-
pared to be flexible with appointments) who provided no
support (e.g., guidance on how to complete the question-
naires) and/or no opportunity to discuss concerns. Con-
versely, participants described helpful clinic staff as an en-
abler to attend appointments. The lack of opportunities to
meet or discuss the trial with other participants was also
cited as barrier. A few participants mentioned not receiv-
ing any questionnaires from the trial office and then an
unexpected call enquiring about the questionnaire, which
they sometimes experienced as “unpleasant” and “rude.”
Most participants believed that returning a questionnaire
was their own decision and that the experiences or views
of other people would not impact their own behavior. Some
participants thought that their clinicians’ and family mem-
bers’ opinion (i.e., whether to continue with the research)
was important to them in relation to completing and return-
ing a questionnaire but they didn’t feel pressure from any-
one to do so. While in most cases participants reported no
direct support requirements from others to attend a clinic
visits, one participant stated that they had asked a family
member for help to complete the questionnaire. 
7.2.8. Emotion 
Participants required to attend follow up clinic appoint-
ments highlighted a number of barriers such as feeling
“stressed,” “anxious,” “strange,” or ‘nervous” about at-
tending the clinic. The reasons reported by participants
for these emotions were mixed but were largely linked
to a lack of contact with other trial participants, unhelpful
trial clinic staff, and concerns about whether any treatment
would be needed. The converse was also reported with
some participants mentioning feeling “glad” and “happy”
to see their friendly healthcare team and/or they wanted to
have a health check-up. 
7.2.9. Goals 
Influences relevant for the goals domain were only iden-
tified by participants considering return of questionnaires.
A few participants felt that completing a questionnaire was
important and hence it was a priority to return it to the trial
office. Although most participants had other, potentially
competing, commitments a few managed to return some
of the questionnaires whether their priorities changed dur-
ing the trial or not. Most participants mentioned not being
able to return the questionnaire as they had other personal
priorities such as dealing with health issues, personal life,
caring responsibilities, and work pressures. 
7.2.10. Memory, attention, and decision processes 
Participants did not mention anything related to forget-
fulness when considering their ability to return a question-
naire, but instead mentioned needing to remember to return
questionnaires. They reported using various strategies to re-
member to complete and return the questionnaires, whichincluded using “post it notes,” “mental notes” and/or leav-
ing the questionnaire in sight as a visual reminder. 
Table 3 presents the identified barriers and enablers and
provides potential solutions to help optimize their impact
on trial retention. 
8. Discussion 
This is the first study to investigate trial participants’ ac-
counts of trial retention through a behavioural perspective
and apply a theoretical framework to understand the bar-
riers and enablers [12] . Our key findings are summarized
in two tables: Tables 2 and 3 . Table 2 helps trial teams to
identify potential barriers and enablers. Table 3 gives prac-
tical suggestions for what trial teams can do about them.
Together we think they will help trial teams to avoid pre-
dictable retention problems. 
This study has shed light on two often essential
trial related retention behaviours: questionnaire return and
follow-up clinic attendance; critical activities for collecting
participant-reported outcome data. Moreover, this study in-
cluded participants from a range of host trials with varied
experiences. Findings suggest that many domains from the
TDF are relevant and important, as enhancers and limiters,
for different trial-related retention behaviours such as ques-
tionnaire return and clinic attendance. This provides the
first step in producing an evidence base from which to de-
velop behavior-change interventions to improve retention
in trials. 
Common barriers frequently reported in relation to both
target behaviors stemmed from participants’ knowledge,
beliefs about their capabilities and the consequences of per-
forming (or not performing) the behavior. This resonates
with the notion that an individual’s knowledge (i.e., about
how many times they have to complete a task during the
trial period) and beliefs often predict behavior, particularly
the perceived ability to complete a task in relation to per-
sonal capabilities and/or time available amongst other pri-
orities in life and the anticipated consequences of perform-
ing a particular action. Another frequent barrier to both
behaviours identified within environmental context and re-
sources (and linked to goals) was time. Whether it was
the time required to complete a questionnaire or attend a
clinic, sometimes by incorporating it as a “day out” (be-
havioral regulation), ensuring the trial could be accommo-
dated within the lives of participants was key to them com-
pleting the trial activities. Of particular note was the belief
by some that there are no consequences associated with not
performing the behavior which manifested itself as a lack
of awareness of their individual contribution. Contrastingly,
whilst participants were aware that their noncompletion of
the trial might result in the trial taking longer, they were
unaware of the impact on trial results from poor reten-
tion. Taken together, the findings suggest that effective be-
havioural interventions to improve retention in trials should
provide a clear and realistic timescale for trial participa-
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tion and highlight the importance of continuing through all
follow-up phases of the project. 
Recent work has highlighted that very little information
is given to potential trial participants about trial retention
(i.e., what can be expected and when) during the con-
sent process but stating the right to withdraw is common-
place [17 , 18] . Improving potential participants’ knowledge
about trial retention could also help to influence beliefs
about capabilities and consequences, through intervention
approaches such as persuasion, modeling, and enhance-
ment, and as such improve data collection. A potential
concern from trial teams might be that improving knowl-
edge and expectations of trial retention at recruitment could
negatively impact on recruitment rates. Equally, we could
speculate that this impact could be offset by improved re-tention; if a person is going to drop out, it’s better for
them to do so at recruitment. However, the net effect is
currently a matter of speculation and such hypotheses need
to be tested. 
Reinforcement, behavioral regulation, and memory were
also reported by participants as barriers to retention with
key linkages between these domains. A lack of reinforce-
ment (e.g., no appreciation for participants taking part in
the trial or no reward provided) was a common barrier to
retention, suggesting that a “reward” may have encouraged
participants. This was supported by a subset of participants
who indicated their appreciation for the shopping vouch-
ers they had received. The Cochrane review of interven-
tions to improve retention to trials has shown that there
is moderate certainty evidence to support the use of mon-









































































































etary incentives as reinforcement to improve postal ques-
tionnaire responses in trials [5] . However, the studies that
evaluate these monetary incentives appear to employ the
use of behavior change techniques in both the comparator
and control groups suggesting further work to maximize
any effect of behavioural components on reinforcement is
needed [19] . Social incentives (such as a thank you note)
for reinforcement of return of postal questionnaires are cur-
rently being investigated [20–22] . 
Several participants indicated that they would have
found it helpful to receive text or phone reminders of up-
coming appointments or to schedule questionnaire comple-
tion. Other participants reported that they had found their
own behavioural strategies to remind them to complete the
allocated task, such as leaving the questionnaire in a visi-
ble location or logging the date in a diary. Others reported
using no strategies to return the questionnaire. It may be
valuable for trial offices to routinely send out reminders
or encourage participants to adopt behavioural strategies
they could use to aid task completion. There is evidence
that the use of electronic prompts (e.g., email/text/both)
can improve response rates to postal questionnaires [23] . 
Many of the relevant domains and proposed strategies
discussed thus far have related to practical aspects of trial
design or conduct. However, a key influence on attendance
at clinic appointments and return of questionnaires (albeit
less so) was social influence and its direct interplay with
emotions. The participants’ perceptions of unfriendly or
unhelpful trial staff at the clinic or the study office was
identified as being important as to whether a participant
completed the behavior. Negative emotions experienced by
participants due to poor communication and/or motivation
from the trial office appeared to be a strong deterrent to
retention. Previous studies have highlighted the importance
of these relational considerations to influence both recruit-
ment and retention [3 , 24] . The other relational aspect high-
lighted by trial participants as being influential for clinic
visits was the opportunity to meet other trial participants to
discuss the trial. This potential for a sense of community
amongst participants and the normalization of trial partic-
ipation as a behavior has also been highlighted previously
[25] . Strengthening relationships between trial participants
and trial staff to enable positive experiences may therefore
have promise, although the operationalization and imple-
mentation of this will likely have its own challenges. It is
worth noting, however, that only one trial in our sample
included attendance at follow-up clinics as part of its data
collection procedure. While this adds to the already scarce
evidence base on attendance at follow-up clinics, more re-
search is needed to understand, for example, whether at-
tendance at routine healthcare appointments that coincide
with trial follow-up visits compared to visits set up for
the purposes of the trial are harder to retain to or indeed
influence responsiveness of staff. 
Some of the key domains that participants identified
as enablers of retention related to participants’ belief thattheir participation was meaningful (beliefs about [positive]
consequences), and the belief that they were helping others
through their participation. Educating, persuading, model-
ing, and enabling participants on the value of trials and
the importance of retention may be an effective behavioral
change strategy. Critiquing what information trial teams
share with participants, and when, should be considered.
It is notable that interventions to improve trial retention
identified to date rarely target such enablers. While in-
terventions more often target the minimization of barri-
ers, these findings indicate that interventions that enhance
or amplify what matters to people when taking part in a
trial also have potential. Many of the findings identified in
this study map onto the priorities for the trial retention re-
search agenda [26] . The top priority identified was “What
motivates a participant’s decision to complete a clinical
trial?” and many of our findings talk to that. However,
the second priority was “How can trials make better use
of routine clinical care and/or existing data collection to
improve retention?” Making better use of routine data col-
lection to minimize problems of poor retention in trials is
not a panacea but certainly has potential to mitigate against
many of the problems identified with regard to completing
and/or attending follow-up. This suggests that considering
retention when designing trials is essential irrespective of
whether considering routine or trial-specific data. 
8.1. Strengths and limitations 
This study adds to the scarce literature and enhances
knowledge of the common barriers and enablers to trial
retention using data from several trials. Exploratory stud-
ies of this nature tend to be embedded within one host
trial, whereas this study included participants across six
trials, so enhancing transferability of findings. This explo-
ration across trials has shown the need to consider the
context of the individual trial (i.e., nature of the partici-
pant group, degree of fit with the trial and intervention de-
sign) when designing interventions to target trial retention.
Furthermore, implementing a validated theoretical behav-
ioral framework enables the design of effective interven-
tions aimed at behavior change. Theoretical frameworks
allow health researchers to target common determinants of
behavior [7 , 8] . Thus, suggested strategies without a theo-
retical basis may be less likely to induce effective change.
Our focus was solely on Phase III pragmatic effectiveness
trials which may limit applicability of our findings to ear-
lier phase trials. 
Some have argued that utilizing the TDF to frame inter-
view topic guides is too prescriptive and leads participants
to verbalize their views and opinions only about the top-
ics covered in the TDF [27] . However, a previous study
compared the use of the TDF with a theoretical methods
using qualitative methodology (interviews, questionnaires
and focus groups) and established that the TDF uncovered
views that were not mentioned in the studies that used a

























































































theoretical topic guides [28] . This highlights that the TDF
does not limit responses from participants. We could only
interview those participants who responded positively to
our letters of invitation (4%) and need to be mindful that
their views may have differed from invited nonresponders
and those from other trials. Moreover, we did not make
special efforts to sample for diversity with regard to char-
acteristics such as ethnicity and socioeconomic status. This
means it is unlikely that we have identified the full range
of barriers and enablers to trial retention for everyone in
our communities. Who our results apply to will become
apparent when the interventions based on these accounts
are tested for their impact on retention. 
Despite these limitations, we were satisfied that our
sample size was sufficient as no new concepts were identi-
fied within the TDF domains over the last three interviews.
This is in line with stopping criterion for theory informed
interviews and the guidance on information power [14 , 29] .
However, the full suite of behavioural barriers and facilita-
tors relating to follow-up clinics is limited as only one of
the trials used such clinics for its data collection schedule.
We note that these TDF-generated findings, resonate with
the major themes identified in a qualitative evidence syn-
thesis of trial retention which included studies that were
not informed by the TDF [3] . However, the current be-
havioural analysis has added insights around the potential
for reinforcement, behavioural regulation, and environmen-
tal context and resource issues and provided more nuanced
understanding of the domains identified in the previous
synthesis. 
8.2. Priorities for further research 
One area for future research is to identify the behavioral
challenges and enablers for trial participants who do stay
in a trial until the end and complete all of the follow-up
activities. These behavioral influences could be compared
with our findings to identify further retention strategies.
There is some suggestion in the literature that people who
complete a trial until the end have been influenced by the
relationships developed with trial staff [24] , the sense of
community with other participants [30] , and their personal
relationships outside the trial [31] – mirroring some of the
aspects identified in this study. In addition, further con-
sideration of the duration of follow-up, the type of clinic
visit being attended (i.e., routine healthcare as part of a
trial or trial-specific), and involvement of individuals often
excluded from research (e.g., people from ethnic minor-
ity groups and people with cognitive impairments [32] ) is
warranted. 
Future studies aiming to invite participants who have
not completed a trial until the end to engage in further
research might consider various strategies to improve re-
sponse, for example, who the invitation letter comes from.
In this study invites were issued from the Trial Chief In-
vestigator; it may be that they need to come from an indi-vidual the participant has formed a relationship with, for
example, the recruiter. The content of the invitation may
also need further refinement and the use of incentives to
engage in the research way also warrants investigation. The
context of the host trial may also influence willingness to
participate. As an example, we observed some differences
in the uptake rate of participants in our sample, where
participants from trials including patients with a “chronic”
ongoing condition (e.g., urinary incontinence postsurgery)
were more responsive than those in an “acute” condition
trial (e.g., treatment for urinary stones). 
9. Conclusion 
This paper has identified barriers and enablers to
trial retention based on participant responses from semi-
structured interviews using a behavioural science approach.
Researchers can use these findings in two ways. Firstly, it
is critical when designing trials to consider barriers and en-
ablers of retention to prevent problems before they arise.
Secondly, these findings can be used to develop participant-
centered behavioural interventions where uncertainties re-
main about the most effective ways to increase retention. 
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